SCD vs Mediterranean diet RCT in adults with Crohn's disease
339 gut metagenome samples from adults with Crohn's disease in the USA, from a randomized trial comparing the Specific Carbohydrate Diet to a Mediterranean diet over 12 weeks. machine-written summary
339 samples · 339 runs · US · Adult · 2024 · 1.92 Gbp / sample
Checked this project's papers and archive records yourself? Mark it human-verified.
what each source gave
| ✓ Sequence archive | 4,041 sample values (collection date, country, diet, diet detail, health condition, intervention, intervention detail, latitude) |
| ○ Abstract / description | read; no usable statement |
| ✓ Full text | 366 sample values (health condition, health condition detail) · PMC8396394 |
| – Supplementary tables | no supplementary tables available (or none open access) |
| – External resources | not covered by the external resources we ingest |
| – User contribution | nothing uploaded yet |
| – Human verified | not yet checked by a person · I checked this project — verify it |
intervention — arms not resolved
Controlled / prescribed diet or feeding regimen design randomized_controlled_trial · population crohns_disease · Specific Carbohydrate Diet vs Mediterranean Diet, 12 weeks
“randomly assigned 1:1 to consume the MD or SCD for 12 weeks” — bioproject.description (study level; per-sample arms are in the intervention column below)
longitudinal
116 of 127 people sampled more than once (302 samples; median 3, up to 3 per person) · follow-up median 3 mo (max 3 mo) · median interval between samples 42 d (time from timepoint labels).
Each row is one person (36 shown of 116); dots are samples at days since that person's first sample.
Genera, mean relative abundance over 279 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).
| field | samples | coverage | R1 | R2 | R3 | R4 |
|---|---|---|---|---|---|---|
| age_category | 339 | 100% | ||||
| country | 339 | 100% | 339 | |||
| health_condition | 339 | 100% | 312 | 27 | ||
| subject_id | 313 | 92% | 313 | |||
| collection_date | 339 | 100% | 339 | |||
| detailed_location | 339 | 100% | ||||
| health_condition_detail | 339 | 100% | 339 | |||
| latitude | 339 | 100% | 339 | |||
| location_region | 339 | 100% | 339 | |||
| longitude | 339 | 100% | 339 | |||
| diet | 313 | 92% | 313 | |||
| diet_detail | 313 | 92% | 313 | |||
| intervention | 313 | 92% | 313 | |||
| intervention_detail | 313 | 92% | 313 | |||
| timepoint_label | 313 | 92% | 313 | |||
| medication | 156 | 46% | 156 |
- A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease. 2021 PMID 34052278 PMC8396394 own_data
Archive description
This study compared the effectiveness of the Specific Carbohydrate Diet (SCD) to the Mediterranean diet (MD) as treatment for Crohn's disease (CD) with mild to moderate symptoms. Adult patients with CD and with mild-to-moderate symptoms were randomly assigned 1:1 to consume the MD or SCD for 12 weeks. For the first 6 weeks, participants received prepared meals and snacks according to their assigned diet. After 6 weeks, participants were instructed to follow the diet independently. The primary outcome was symptomatic remission at week 6. Key secondary outcomes at week 6 included fecal calprotectin (FC) response (FC <250 g/g and reduction by >50% among those with baseline FC >250 g/g) and C-reactive protein (CRP) response (high-sensitivity CRP <5 mg/L and >50% reduction from baseline among those with high-sensitivity CRP >5 mg/L). The study randomized 194 patients, and 191 were included in the efficacy analyses. The percentage of participants who achieved symptomatic remission at week 6 was not superior with the SCD (SCD, 46.5% MD, 43.5% P = .77). FC response was achieved in 8 of 23 participants (34.8%) with the SCD and in 4 of 13 participants (30.8%) with the MD (P = .83). CRP response was achieved in 2 of 37 participants (5.4%) with the SCD and in 1 of 28 participants (3.6%) with the MD (P = .68). The SCD was not superior to the MD to achieve symptomatic remission, FC response, and CRP response. CRP response was uncommon. Given these results, the greater ease of following the MD and other health benefits associated with the MD, the MD may be preferred to the SCD for most patients with CD with mild to moderate symptoms. ClinicalTrials.gov Identifier: NCT03058679
How this project entered the registry
Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.
- host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
- body site study.description · “week 6 included fecal calprotectin (FC) response”
- body site external_curation.infant_catalog · “body_site_call gut”
- life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
- life stage study.title · “Mediterranean Diet in Adults With Crohn's Disease”
Evidence examples (one per field × route)
| sample | field | value | route | conf. | source | quote |
|---|---|---|---|---|---|---|
| SAMN29470759 | collection_date | 2017 | R1 | 0.90 | biosample.attribute:collection_date | 2017 |
| SAMN29470759 | country | US | R1 | 0.90 | sample.attr.geo_loc_name | USA |
| SAMN29470759 | diet | therapeutic_or_study_diet | R1 | 0.90 | biosample.attribute:diet | SCD |
| SAMN29470759 | diet_detail | SCD | R1 | 0.90 | biosample.attribute:diet | SCD |
| SAMN29470759 | health_condition | crohns_disease | R1 | 0.70 | biosample_attr | Ileum alone |
| SAMN29470916 | health_condition | crohns_disease | R3 | 0.70 | paper.abstract | Adult patients with CD and with mild-moderate symptoms were randomly assigned 1:1 |
| SAMN29470759 | health_condition_detail | Crohn's disease (CD) | R3 | 0.70 | paper.abstract | Adult patients with CD and with mild-moderate symptoms were randomly assigned 1:1 |
| SAMN29470759 | intervention | diet_intervention | R1 | 0.80 | biosample.attribute:Diet | Diet: SCD |
| SAMN29470759 | intervention_detail | Specific Carbohydrate Diet | R1 | 0.80 | biosample.attribute:Diet | Diet: SCD |
| SAMN29470759 | latitude | 39.9473 | R1 | 0.90 | biosample.attribute:lat_lon | 39.9473 N 75.1958 W |
| SAMN29470759 | location_region | Pennsylvania | R1 | 0.60 | biosample.attribute:lat_lon | 39.9473 N 75.1958 W |
| SAMN29470759 | longitude | -75.1958 | R1 | 0.90 | biosample.attribute:lat_lon | 39.9473 N 75.1958 W |
| SAMN29470762 | medication | immunosuppressant_or_biologic | R1 | 0.85 | biosample.attribute:biologic_at_baseline | 1 |
| SAMN29470759 | subject_id | 10237250 | R1 | 0.85 | sample.attr.subjectid | 10237250 |
| SAMN29470759 | timepoint_label | W0 | R1 | 0.85 | sample.attr.study_week | W0 |
Sequencing
339 runs over 339 samples · mean 1.84 Gbp per run (median 1.92 Gbp, total 622.81 Gbp; 339 runs with a base count) · layout PAIRED 339 · platform ILLUMINA 339 · models Illumina HiSeq 2500 (339) · 82% of runs with a Sandpiper profile · first public 2024-06-30
Authors (0)
No author record.
Downloads
PRJNA854889.csv.gz (10.7 KB) · parquet (85.2 KB) — all 339 samples, every field with route and confidence · PRJNA854889_determinations.csv.gz (29.6 KB) — 4,407 evidence rows